|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | ||||||
| Financial Assets classified as Loans and Receivables | ||||||
| Other Financial Assets | ||||||
| Other Financial Assets at Amortized Cost | ||||||
| Accounts Receivable | ||||||
| Financial Assets from Collaborations | ||||||
| Income Tax Receivables | ||||||
| Other Receivables | ||||||
| Inventories | ||||||
| Prepaid Expenses and Other Assets | ||||||
| Total Current Assets | ||||||
| Non-Current Assets | ||||||
| Property, Plant and Equipment | ||||||
| Right-of-Use Assets | ||||||
| Intangible Assets | ||||||
| Goodwill | ||||||
| Other Financial Assets | ||||||
| Investment in Associates | ||||||
| Deferred Tax Asset | ||||||
| Prepaid Expenses and Other Assets | ||||||
| Total Non-Current Assets | ||||||
| TOTAL ASSETS | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| Current Liabilities | ||||||
| Accounts Payable and Accruals | ||||||
| Lease Liabilities | ||||||
| Tax Liabilities | ||||||
| Provisions | ||||||
| Contract Liability | ||||||
| Bonds | ||||||
| Financial Liabilities from Collaborations | ||||||
| Financial Liabilities from Future Payments to Royalty Pharma | ||||||
| Total Current Liabilities | ||||||
| Non-Current Liabilities | ||||||
| Lease Liabilities | ||||||
| Provisions | ||||||
| Contract Liability - thereof long-term | ||||||
| Deferred Tax Liability | ||||||
| Bonds | ||||||
| Financial Liabilities from Collaborations | ||||||
| Financial Liabilities from Future Payments to Royalty Pharma | ||||||
| Total Non-Current Liabilities | ||||||
| Total Liabilities | ||||||
| Stockholders’ Equity | ||||||
| Common Stock | ||||||
| Treasury Stock (53,685 and 65,980 shares for 2023 and 2022, respectively), at Cost | ||||||
| Additional Paid-in Capital | ||||||
| Other Comprehensive Income Reserve | ||||||
| Accumulated Deficit | ||||||
| Total Stockholders’ Equity | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
Loading...
